Evidence map›Paper›PMID 22968219›Full record

ArticleThe Diabetes educator

En Balance: the effects of Spanish diabetes education on physical activity changes and diabetes control.

Gina Wheeler, Susanne B Montgomery, Larry Beeson, Khaled Bahjri, Eloy Shulz, Anthony Firek, Marino De Leon, Zaida Cordero-MacIntyre

Registry-linked trialOpen access · greenAbstract readEvaluation Study
In one paragraph

Article in The Diabetes educator. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07720388 (Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07720388 nanot yet recruitingnot on this map

Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

TypeinterventionalSponsorUniversity of Colorado, DenverRan2026 to 2027Enrolled15ConditionsDiabetes Mellitus, Type 1 DiabetesArmsCulturally and linguistically tailored onboarding and support program, Medtronic MiniMed 780G Insulin Pump System
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gina WheelerLoma Linda University, School of Public Health, Preventive Care Program, Loma Linda, California (Dr Wheeler)
Susanne B MontgomerySchool of Medicine, and School of Behavioral Health, Loma Linda, California (Dr Montgomery)
Larry BeesonLoma Linda University, School of Public Health, Department of Epidemiology and Biostatistics, Loma Linda, California (Dr Beeson, Dr Bahjri)
Khaled BahjriLoma Linda University, School of Public Health, Department of Epidemiology and Biostatistics, Loma Linda, California (Dr Beeson, Dr Bahjri)
Eloy ShulzLoma Linda University, School of Medicine, Department of Radiology, Loma Linda, California (Dr Shulz)
Anthony FirekEndocrinology Section, JL Pettis Memorial VA Medical Center, Loma Linda, California (Dr Firek)
Marino De LeonLoma Linda University, Center for Health Disparities and Molecular Medicine (Dr De Leon, Dr Cordero-MacIntyre)
Zaida Cordero-MacIntyreLoma Linda University, School of Public Health, Department of Nutrition, Loma Linda, California (Dr Cordero-MacIntyre)
Loma Linda University · US

Funding

The role of imidazoline receptor in type-2 diabetesP20MD001632 · NIMHD · LOMA LINDA UNIVERSITY · PI DE LEON, DAISY D. · 2005 to 2009
$8.0M
Research Training/Education CoreP20MD006988 · NIMHD · LOMA LINDA UNIVERSITY · PI CASIANO, CARLOS A. · 2012 to 2016
$6.2M
NIMHD NIH HHS 5P20MD001632NIMHD NIH HHS P20 MD001632NIMHD NIH HHS P20 MD006988
6 · The paper itself

Abstract

purposeThis study was designed to assess the feasibility of culturally and language-sensitive diabetes education as a way to increase physical activity and to improve health/diabetes management in a group of Spanish-speaking Hispanics in the Inland Empire region of Southern California.

methodsEn Balance is a culturally sensitive diabetes education program designed for Spanish-speaking Hispanic adults. The 3-month educational intervention assessed 16 males and 23 females living in Riverside and San Bernardino counties of Southern California. Baseline and 3-month evaluations of physical activity were assessed using the validated Arizona Activity Frequency Questionnaire.

resultsAfter 3 months on the En Balance program, there was a significant increase in moderate intensity physical activity energy expenditure (M = 368 ± 894 kcal/day, P < 0.01) and high intensity physical activity energy expenditure (M = 405 ± 2569 kcal/day, P = 0.05) compared to baseline and significant reductions in A1C (-0.90%, P = 0.01), total cholesterol (-13.44 mg/dl, P = 0.01), LDL cholesterol (-10.28 mg/dl, P = 0.03), and waist circumference (-1.52 cm, P = 0.04).

conclusionEn Balance program resulted in significant mean increases in both moderate and high intensity physical activity energy expenditure among this group of Hispanic diabetic participants, indicating that despite a general pattern of low physical activity in this group, an intervention that stresses both nutrition and exercise in culturally sensitive ways can positively impact participant's physical activity levels as well as impact nutritional changes.

Indexed as

Energy MetabolismHispanic or LatinoAdultAgedCaliforniaCultural CharacteristicsDiabetes Mellitus, Type 2ExerciseFemaleHumansLanguageMaleMiddle AgedNutritional StatusPatient Education as TopicYoung Adult

Identifiers

PMID22968219
PMCPMC3885415
OpenAlexW2155967631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.